Title Physician

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition)

NCT ID : 04720157
Protocol Number : JWC_CAAA617C12301 (Novartis)
Phase : III
Location : Santa Monica, Ca
Przemyslaw Twardowski, M.D.

Prospective, Multi-Center, Randomized Study To Assess The Ability Of The Hydriphilix HDX Urinary Catheter To Reduce BIOFILM Formation When Compared To Two Types Of Commercially Available Foley Catheters (LATEX INFECTION CONTROL AND SILICONE-COATED LATEX)

NCT ID : 04841226
Protocol Number : JWC_STC-001
Phase : 3
Location : Santa Monica, CA
Jennifer Linehan, M.D.

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC (CONTACT-02)

NCT ID : 04446117
Protocol Number : XL184-315
Phase : 3
Location : Santa Monica, CA
Przemyslaw Twardowski, M.D.

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

NCT ID : 04519879
Protocol Number : White Button Mushroom
Phase : 2
Location : Santa Monica, CA
Przemyslaw Twardowski, M.D.

Evaluation of the PhageTech Virus BioResistor

NCT ID : 04756284
Protocol Number : VBRm BCA-01
Phase : Pilot/Feasibility
Location : Santa Monica, CA
Jennifer Linehan, M.D.

A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (ATLAS)

NCT ID : 04688931
Protocol Number : BL006
Phase : 3
Location : Santa Monica, CA
Jennifer Linehan, M.D.

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib (MK-7902) Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

NCT ID : 04586231
Protocol Number : Merck -6482-011
Phase : 3
Location : Santa Monica
Przemyslaw Twardowski, M.D.

Enfortumab Vedotin and Pembrolizumab, With or Without Chemotherapy, vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (EV-302)

NCT ID : 04223856
Protocol Number : SGN22E-003
Phase : 3
Location : Santa Monica, CA
Przemyslaw Twardowski, M.D.

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

NCT ID : 03924856
Protocol Number : MK-3475-866/KEYNOTE-866
Phase : 3
Location : Santa Monica, CA
Przemyslaw Twardowski, M.D.